INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.

Medical Freedom Maps

Home » Maps » Right to try » New Hampshire

Right to try in New Hampshire

Right to try laws and requirements in New Hampshire. Citations, verification dates, and source links for every data point.

DimensionValueCitationSourceVerifiedConfidence
Have Enacted State Right to Try Lawshave state RTT lawsN.H. Rev. Stat. Ann. § 126-Z:2, I“A manufacturer of an investigational drug, biologic, or device may make available an investigational drug, biologic, or device to eligible patients pursuant to this chapter.”Link2026-10-09high
Enacted Right to Try Laws Before Federal Law20162016 N.H. Laws ch. 206:2“Source. 2016, 206:2, eff. June 6, 2016.”Note: Stored 2017 is wrong. Chapter 126-Z source notes show the act was 2016 chapter 206, effective June 6, 2016; later amended by 2024 ch. 124, 2025 ch. 304 (HB 701, 'John Lewicke and Michael Yakubovich Right to Try Act', eff. Jan. 1, 2026) and 2026 ch. 311 (contingent).Link2026-10-09high
Require Individualized Manufacturer Approval for RTTrequire individualized approvalN.H. Rev. Stat. Ann. § 126-Z:1, I-c; § 126-Z:3, III(e)“"Individualized investigational treatment" means drugs, biologics, or devices unique to and produced exclusively for use for an individual patient, based on their own genetic profile, including but not limited to individualized gene therapy antisense oligonucleotides (ASO)”Note: Individualized investigational treatment provisions are enacted in RSA 126-Z (definition I-c; immunity for individualized treatments administered at an eligible facility, 126-Z:3, III(e)); 'qualifying severe illness' (chronic and debilitating) also covered. Caveat: the version shown on gc.nh.gov is labeled 'effective upon certified approval of a legislative report ... pursuant to 2026, 311:21' and the currently-effective text is not displayed, so it is unclear whether these provisions came from 2024 ch. 124 or 2026 ch. 311 and whether they are yet in force; either way they were signed into law. NH is also in the reported list of enacting states.Link2026-10-09high
Provide Manufacturer Liability Protection Under RTTprovide liability shield sources differN.H. Rev. Stat. Ann. § 126-Z:3, III“a manufacturer of a drug, biologic, or device, a pharmacist, a health care facility, a health care provider, or a person or entity involved in the care of a patient using a drug, biologic, or device is immune from suit”Note: Immunity clause (not merely 'no private cause of action'), conditioned on terminal/qualifying severe illness, no comparable FDA-approved options, informed consent, and no 'willful or reckless misconduct or other bad faith conduct'. Ambiguous only as to timing: the displayed text is the version 'effective upon certified approval of a legislative report ... pursuant to 2026, 311:21' (source: 2016, 206:2; 2024, 124:1; 2025, 304:3; 2026, 311:15 contingent); the currently effective version is not shown on gc.nh.gov. Best value true. RSA 126-Z:4, I also says nothing in the chapter creates a private cause of action except injunctive relief against regulators.Link2026-10-09medium
Require Insurer Coverage of Investigational Treatmentsdo not require coverageN.H. Rev. Stat. Ann. § 126-Z:2, II“This chapter shall not require a health care insurer or any state agency to provide coverage for the cost of any investigational drug, biologic, or device.”Link2026-10-09high

View full New Hampshire profile (all layers) · Report an error on this page

Methodology: every value was checked in October 2026 against a specific source (statute, regulator or official list, or a named tracker page), and each links to that page with a short quote. Values no source could support are shown as “Not verified”. Verification was AI-assisted and spot-checked; laws change, so confirm with the linked source before relying on a value. How values are verified · Report an error.